Health Financing: Does Governance Quality Matter مقاله

نویسنده: Sirag، Abdalla ؛ Mohamed Nor، Norashidah ؛ Mustapha Raja Abdullah، Nik ؛

Iranian Economic Reveiw Summer 2017, Volume 21 - Number 3 رتبه علمی-پژوهشی (وزارت علوم/ISC (‎31 صفحه - از 693 تا 723 )

کلیدواژه ها: Health Care Health Financing Governance Quality System-GMM GDP GMM TB AR Lu However

چکیده:

This paper contributes to the existing literature by examining the determinants of health financing in 177 developed and developing countries. The study introduces the variables of government effectiveness and control of corruption to capture the impact of governance quality on different mechanisms of health financing. Utilisng panel data analysis, namely system-GMM estimators, to obtain unbiased estimates, the results indicate that public and private health financing do not follow the same pattern. In addition, the GDP per capita and total government expenditure is crucial factors that affect health financing in both developed and developing countries. External aid tends to reduce public health financing, especially when it is received by a country with low governance quality. Interestingly, a high level of government effectiveness and control of corruption are found to be very influential in stimulating public health financing and helping to reduce private health financing in developed countries. However, the low amounts of health financing in developing countries are attributable to the low quality of governance, which increases out-of-pocket health financing.

خلاصه ماشینی:

Furthermore, Liang &amp; Mirelman (2014) examined the impact of socio-political factors, such as democratic accountability and corruption, and external aid on public health financing in 120 developed and developing countries from 1995 to 2010, using fixed-effects and two-stage least squares. 1 Model specification This study attempts to estimate the influencing factors of different health financing mechanisms, which can be written as: lnHFit  δHFit 1  β1lnGDPit  β 2lnHFM it  β 3lnEX Fit  β 4lnGGE it  β 5lnT B it  β 5lnPOPit  μ i  λt  υ it (1) where , , and refer to the country-specific effect, time effect, and error term, respectively, refers to the country, is time, is the dependent variables such as public PHF, private PRHF, or total health financing THF as a percentage of the GDP or out-of-pocket OOP as share of total health expenditure, is the GDP per capita at the 2005 US$ constant price, is the health financing mechanisms to test the substitution effect between different components of health financing1, is external resources for health (development assistance for health) as share of total health expenditure, which is only included in developing countries estimation, is the general government expenditure as a ratio of the GDP, is the incidence of tuberculosis to capture the impact of disease patterns on different types of financing, and is the population aged over 65 years as a share of the total population. Table 2 presents the findings of the public health financing model for developed countries, first without including institutional variables, second including government effectiveness, and third including control of corruption.

دریافت فایل ارجاع :
(پژوهیار, , , )

دانلود PDF
دانلود HTML

لینک کوتاه:

صفحه:

ورود / عضویت

برای مشاهده متن مقاله و یا دانلود آن لازم است وارد پایگاه شوید. در صورتی که عضو نیستید از قسمت عضویت اقدام فرمایید.

ورود